These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 18484575)

  • 1. Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks.
    Darbre PD; Harvey PW
    J Appl Toxicol; 2008 Jul; 28(5):561-78. PubMed ID: 18484575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine disrupters and human health: could oestrogenic chemicals in body care cosmetics adversely affect breast cancer incidence in women?
    Harvey PW; Darbre P
    J Appl Toxicol; 2004; 24(3):167-76. PubMed ID: 15211609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesis.
    Harvey PW
    J Appl Toxicol; 2003; 23(5):285-8. PubMed ID: 12975767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours.
    Harvey PW; Everett DJ
    J Appl Toxicol; 2004; 24(1):1-4. PubMed ID: 14745840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment of esters of p-hydroxybenzoic acid (parabens).
    Soni MG; Carabin IG; Burdock GA
    Food Chem Toxicol; 2005 Jul; 43(7):985-1015. PubMed ID: 15833376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal care products and endocrine disruption: A critical review of the literature.
    Witorsch RJ; Thomas JA
    Crit Rev Toxicol; 2010 Nov; 40 Suppl 3():1-30. PubMed ID: 20932229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines.
    Pugazhendhi D; Pope GS; Darbre PD
    J Appl Toxicol; 2005; 25(4):301-9. PubMed ID: 16021681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible endocrine disrupting effects of parabens and their metabolites.
    Boberg J; Taxvig C; Christiansen S; Hass U
    Reprod Toxicol; 2010 Sep; 30(2):301-12. PubMed ID: 20381602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parabens: potential impact of low-affinity estrogen receptor binding chemicals on human health.
    Karpuzoglu E; Holladay SD; Gogal RM
    J Toxicol Environ Health B Crit Rev; 2013; 16(5):321-35. PubMed ID: 23909435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of parabens in human breast tumours.
    Darbre PD; Aljarrah A; Miller WR; Coldham NG; Sauer MJ; Pope GS
    J Appl Toxicol; 2004; 24(1):5-13. PubMed ID: 14745841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects.
    Prusakiewicz JJ; Harville HM; Zhang Y; Ackermann C; Voorman RL
    Toxicology; 2007 Apr; 232(3):248-56. PubMed ID: 17306434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture.
    Jewell C; Prusakiewicz JJ; Ackermann C; Payne NA; Fate G; Voorman R; Williams FM
    Toxicol Appl Pharmacol; 2007 Dec; 225(2):221-8. PubMed ID: 17889094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do parabens have the ability to interfere with steroidogenesis?
    Taxvig C; Vinggaard AM; Hass U; Axelstad M; Boberg J; Hansen PR; Frederiksen H; Nellemann C
    Toxicol Sci; 2008 Nov; 106(1):206-13. PubMed ID: 18648085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental oestrogens, cosmetics and breast cancer.
    Darbre PD
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):121-43. PubMed ID: 16522524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The controversies of parabens - an overview nowadays.
    Petric Z; Ružić J; Žuntar I
    Acta Pharm; 2021 Mar; 71(1):17-32. PubMed ID: 32697748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parabens can enable hallmarks and characteristics of cancer in human breast epithelial cells: a review of the literature with reference to new exposure data and regulatory status.
    Darbre PD; Harvey PW
    J Appl Toxicol; 2014 Sep; 34(9):925-38. PubMed ID: 25047802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse antagonist activities of parabens on human oestrogen-related receptor γ (ERRγ): in vitro and in silico studies.
    Zhang Z; Sun L; Hu Y; Jiao J; Hu J
    Toxicol Appl Pharmacol; 2013 Jul; 270(1):16-22. PubMed ID: 23583298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogenic activity of isobutylparaben in vitro and in vivo.
    Darbre PD; Byford JR; Shaw LE; Horton RA; Pope GS; Sauer MJ
    J Appl Toxicol; 2002; 22(4):219-26. PubMed ID: 12210538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.